Skandinaviska Enskilda Banken (SEB)’s Guardant Health GH Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-731	Closed	-$45.7K	–	758
2025 Q3	$45.7K	Sell	731 -23,567	-97%	-$1.28M	﹤0.01%	757
2025 Q2	$1.26M	Hold	24,298	–	–	0.01%	628
2025 Q1	$1.03M	Buy	+24,298	New	+$1.05M	0.01%	635
2022 Q3	–	Sell	-13,068	Closed	-$527K	–	950
2022 Q2	$527K	Buy	13,068 +1,398	+12%	+$69.3K	﹤0.01%	797
2022 Q1	$773K	Sell	11,670 -4,182	-26%	-$286K	﹤0.01%	790
2021 Q4	$1.59M	Sell	15,852 -42,968	-73%	-$4.44M	0.01%	698
2021 Q3	$7.35M	Sell	58,820 -5,106	-8%	-$607K	0.04%	342
2021 Q2	$7.94M	Buy	63,926 +47,404	+287%	+$6.38M	0.05%	332
2021 Q1	$2.52M	Buy	+16,522	New	+$2.5M	0.02%	587
2020 Q3	–	Sell	-2,400	Closed	-$195K	–	1066
2020 Q2	$195K	Buy	+2,400	New	+$193K	﹤0.01%	917

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s GH Position: Q4 2025 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Guardant Health (GH) in Q4 2025, closing a stake of 731 shares — an estimated $45.7K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in GH in Q2 2020 and held it in 10 quarters. The position peaked at $7.94M in Q2 2021. 497 funds tracked by Wall St. Rank hold GH as of Q4 2025.

Skandinaviska Enskilda Banken (SEB) reported no remaining Guardant Health position as of Q4 2025 after selling out during the quarter.
Skandinaviska Enskilda Banken (SEB) sold 731 Guardant Health shares in Q4 2025, an estimated $45.7K.
Skandinaviska Enskilda Banken (SEB) first reported a position in Guardant Health in Q2 2020 and held it in 10 quarters.
Skandinaviska Enskilda Banken (SEB)'s Guardant Health position peaked at $7.94M in Q2 2021.
497 funds tracked by Wall St. Rank held Guardant Health as of Q4 2025.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q4 2025, filed 12 Feb 2026.